Epigenetic Silencing of RIPK3 in Hepatocytes Prevents MLKL-mediated Necroptosis From Contributing to Liver PathologiesSimon Preston, Marc Pellegrini, James P. Cooney et al.|Gastroenterology|2022Cited by 71
Impact of viral hepatitis aetiology on survival outcomes in hepatocellular carcinoma: A large multicentre cohort studyS. Mgaieth, Stuart K. Roberts, William Kemp et al.|Journal of Viral Hepatitis|2017Cited by 19
Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort studyKurvi Patwala, Anouk Dev, David Prince et al.|Hepatology International|2022Cited by 15
Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisationStuart K. Roberts, Gauri Mishra, Anouk Dev et al.|BMC Cancer|2020Cited by 13